Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence

Overview

Journal Infect Dis Obstet Gynecol

Publisher Wiley

Specialties Gynecology & Obstetrics
Infectious Diseases

Date 2021 Mar 29

PMID 33776406

Citations 12

Authors

Maria Teresa Bruno

Nazario Cassaro

Francesca Bica

Sara Boemi

Affiliations

Soon will be listed here.

Abstract

Objective: The natural history of the CIN1 lesions is characterized by an elevated rate of spontaneous regression (80%), some authors recognize a capacity to progress to HSIL in 10% of cases, and other authors do not recognize the capacity of progression of LSIL (CIN1). This study was aimed to evaluate the incidence of progression to HSIL (CIN3) in women with a histological diagnosis of LSIL (CIN1). Furthermore, to this end, we studied the histological outcomes of cone specimens collected by the LEEP.

Methods: All the data were retrospectively analyzed. All participants underwent a follow-up of 4 years, during which each woman underwent an HPV test and genotyping, cervical cytological sampling, or biopsy every six months. The endpoint was the histological confirmation of CIN3 lesions in any moment during follow-up.

Results: Progression to CIN3 occurred in 7 cases (1,5%). Analyzing the histological exams of the cones of the 7 cases that progressed to CIN3, we found the coexistence of CIN1 and CIN3 lesions in all cases.

Conclusion: After 4 years of follow-up, only 1.5% (7/475) of the women with LSIL developed CIN3, all within the first two years of follow-up, and were immediately treated. The most likely explanations for "progression" from LSIL to HSIL are (1) actual progression, (2) underdiagnosis of HSIL on initial biopsy, (3) overdiagnosis of HSIL on follow-up biopsy/cone, and (4) CIN3 arose de novo. Analyzing the histological exams of the cones of the 7 cases that progressed to high-grade, we found the coexistence of CIN1 and CIN3 lesions in all cases. Some recent studies have shown that a viral genotype corresponds to different lesions in the same cervix; therefore, CIN1 coexisting with CIN3 does not always indicate progression of CIN1. Other authors have doubted the capacity of LSIL to progress.

Citing Articles

Sexually transmitted human papillomavirus and related sequelae.

Hanft W, Stankiewicz Karita H, Khorsandi N, Vohra P, Plotzker R Clin Microbiol Rev. 2025; 38(1):e0008523.

PMID: 39950806 PMC: 11905373. DOI: 10.1128/cmr.00085-23.

Effectiveness of the Traditional Japanese Herbal Medicine, Yokuinin (Kampo), in the Treatment of Cervical Precancerous Lesions.

Kiyoshima C, Kimura I, Ishida K, Hirano T, Ishida T, Shigekawa K Cureus. 2025; 17(1):e77114.

PMID: 39925535 PMC: 11802933. DOI: 10.7759/cureus.77114.

The Relationship Between Cervicovaginal Infection, Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia in Romanian Women.

Braila A, Poalelungi C, Albu C, Damian C, Dra L, Banateanu A Diseases. 2025; 13(1).

PMID: 39851482 PMC: 11764336. DOI: 10.3390/diseases13010018.

HPV induced R-loop formation represses innate immune gene expression while activating DNA damage repair pathways.

Templeton C, Laimins L PLoS Pathog. 2024; 20(8):e1012454.

PMID: 39178326 PMC: 11376575. DOI: 10.1371/journal.ppat.1012454.

Cervical Intraepithelial Neoplasia Grade 3 (CIN3) in Women Younger than 30 Years Was Significantly Associated with HPV16/18 Genotypes.

Bruno M, Panella M, Valenti G, Ruggeri Z, Sgalambro F, Reina S Cancers (Basel). 2024; 16(11).

PMID: 38893161 PMC: 11171186. DOI: 10.3390/cancers16112043.

References

Ostor A . Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993; 12(2):186-92. View

Jordan J, Martin-Hirsch P, Arbyn M, Schenck U, Baldauf J, da Silva D . European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology. 2009; 20(1):5-16. DOI: 10.1111/j.1365-2303.2008.00636.x. View

Darragh T, Colgan T, Cox J, Heller D, Henry M, Luff R . The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012; 16(3):205-42. DOI: 10.1097/LGT.0b013e31825c31dd. View

Park J, Sun D, Genest D, Trivijitsilp P, Suh I, Crum C . Coexistence of low and high grade squamous intraepithelial lesions of the cervix: morphologic progression or multiple papillomaviruses?. Gynecol Oncol. 1998; 70(3):386-91. DOI: 10.1006/gyno.1998.5100. View

Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J . One virus, one lesion--individual components of CIN lesions contain a specific HPV type. J Pathol. 2011; 227(1):62-71. DOI: 10.1002/path.3970. View

Bruno M, Cassaro N, Garofalo S, Boemi S . HPV16 persistent infection and recurrent disease after LEEP. Virol J. 2019; 16(1):148. PMC: 6882012. DOI: 10.1186/s12985-019-1252-3. View

Woodman C, Collins S, Winter H, Bailey A, Ellis J, Prior P . Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001; 357(9271):1831-6. DOI: 10.1016/S0140-6736(00)04956-4. View

Winer R, Kiviat N, Hughes J, Adam D, Lee S, Kuypers J . Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis. 2005; 191(5):731-8. DOI: 10.1086/427557. View

Massad L, Einstein M, Huh W, Katki H, Kinney W, Schiffman M . 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013; 121(4):829-846. DOI: 10.1097/AOG.0b013e3182883a34. View

10.

Schiffman M, Burk R, Boyle S, Raine-Bennett T, Katki H, Gage J . A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results. J Clin Microbiol. 2014; 53(1):52-9. PMC: 4290932. DOI: 10.1128/JCM.02116-14. View

11.

Stoler M, Schiffman M . Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001; 285(11):1500-5. DOI: 10.1001/jama.285.11.1500. View

12.

Pretorius R, Peterson P, Azizi F, Burchette R . Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less. Am J Obstet Gynecol. 2006; 195(5):1260-5. DOI: 10.1016/j.ajog.2006.07.036. View

13.

Smith J, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R . Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007; 121(3):621-32. DOI: 10.1002/ijc.22527. View

14.

Skinner S, Wheeler C, Romanowski B, Castellsague X, Lazcano-Ponce E, Del Rosario-Raymundo M . Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study. Int J Cancer. 2015; 138(10):2428-38. PMC: 4787275. DOI: 10.1002/ijc.29971. View

15.

Bruno M, Scalia G, Cassaro N, Boemi S . Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression. BMC Cancer. 2020; 20(1):444. PMC: 7236333. DOI: 10.1186/s12885-020-06946-7. View

16.

Litjens R, Van de Vijver K, Hopman A, Ummelen M, Speel E, Sastrowijoto S . The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3. Hum Pathol. 2014; 45(2):221-6. DOI: 10.1016/j.humpath.2013.10.014. View

17.

Richart R, Barron B . A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol. 1969; 105(3):386-93. DOI: 10.1016/0002-9378(69)90268-3. View

18.

Chen E, Tran A, Raho C, Birch C, Crum C, Hirsch M . Histological 'progression' from low (LSIL) to high (HSIL) squamous intraepithelial lesion is an uncommon event and an indication for quality assurance review. Mod Pathol. 2010; 23(8):1045-51. DOI: 10.1038/modpathol.2010.85. View

19.

Moscicki A, Shiboski S, Hills N, Powell K, Jay N, Hanson E . Regression of low-grade squamous intra-epithelial lesions in young women. Lancet. 2004; 364(9446):1678-83. DOI: 10.1016/S0140-6736(04)17354-6. View

20.

Jaisamrarn U, Castellsague X, Garland S, Naud P, Palmroth J, Del Rosario-Raymundo M . Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS One. 2013; 8(11):e79260. PMC: 3834039. DOI: 10.1371/journal.pone.0079260. View